Stock Screener ETF Screener

Penny Stock Screener Technical Analysis Screener

Dividend Center Best Dividend Stocks

Best High Yield Dividend Stocks Dividend Aristocrats Dividend Stock Comparison

Dividend Calculator Dividend Returns Comparison Dividend Calendar

My Experts Top Analysts Top Financial Bloggers Top-Performing Corporate Insiders Top Hedge Fund Managers Top Research Firms Top Individual Investors

Trending News

Education

Personal Finance How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire

Follow Us

TOOLS

Top Insiders Stocks

Notification Center

Penny Stock Screener

Technical Analysis Screener

Top Analyst Stocks

Top Smart Score Stocks

AI Analyst Top Stocks

Top Insiders Stocks

Trending Stocks

Daily Analyst Ratings

Daily Insiders Trades

Dividend Stocks

Top Gainers/losers/active ETFs

Trump Dashboard

Dividend Calculator

Options Profit Calculator

Dollar Cost Averaging

Compound Interest Calculator

Mortgage Calculator

Auto Loan Calculator

Student Loan Calculator

401k Retirement Calculator

Earnings Calendar

Dividend Calendar

Economic Calendar

Market Holidays

Dividend Center

Best Dividend Stocks

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Personal Finance Center

Investing & Retirement

Spending & Savings

Top Online Brokers

Enterprise Solutions

Plans & Pricing

Education

How To Use TipRanks

About Us

Working with TipRanks

Enterprise Solutions

Top Online Brokers

Become an Affiliate

TipRanks News Wire

Follow Us

STOCKS

KalVista Pharmaceuticals (KALV)

NASDAQ:KALV

US Market

KALV

KalVista Pharmaceuticals

Analyst Forecasts

AI Stock Analysis

Technical Analysis

Historical Prices

News & Insights

RESEARCH TOOLS

Top Analyst Stocks

Top Smart Score Stocks

reports

Advertisement

KalVista Pharmaceuticals (KALV) Stock News & Sentiment

520 Followers

KalVista Pharmaceuticals Updates Stockholder Meeting Schedule

Company Announcements

KalVista Pharmaceuticals Updates Stockholder Meeting Schedule

7d ago

Buy Rating for KalVista Pharmaceuticals: Strong Growth Potential Following Ekterly’s FDA Approval and Strategic Financial Positioning

Ratings

Buy Rating for KalVista Pharmaceuticals: Strong Growth Potential Following Ekterly’s FDA Approval and Strategic Financial Positioning

1M ago

KalVista Pharmaceuticals: EKTERLY Launch and Financial Update

Company Announcements

KalVista Pharmaceuticals: EKTERLY Launch and Financial Update

2M ago

KalVista Pharmaceuticals: Buy Rating Affirmed Amidst Promising Ekterly Launch and Strong Financial Position

Ratings

KalVista Pharmaceuticals: Buy Rating Affirmed Amidst Promising Ekterly Launch and Strong Financial Position

2M ago

Buy Rating for KalVista Pharmaceuticals Amid Ekterly’s Market Launch and Insurance Challenges

Ratings

Buy Rating for KalVista Pharmaceuticals Amid Ekterly’s Market Launch and Insurance Challenges

2M ago

Buy Rating for KalVista Pharmaceuticals Driven by FDA Approval and Strategic Market Entry of Ekterly

Ratings

Buy Rating for KalVista Pharmaceuticals Driven by FDA Approval and Strategic Market Entry of Ekterly

2M ago

KalVista Pharmaceuticals Gains FDA Approval for EKTERLY®

Company Announcements

KalVista Pharmaceuticals Gains FDA Approval for EKTERLY®

2M ago

More KALV News >

KALV News on the Web

2025-07-16

KalVista Secures UK Approval For EKTERLY, First Oral On-Demand Treatment For Hereditary Angioedema

rttnews

Neutral

2025-07-11

KalVista Pharmaceuticals: EKTERLY Launch and Financial Update

TipRanks News

Neutral

2025-07-11

Why KalVista Pharmaceuticals, Inc.’s (KALV) Stock Is Down 7.35%

AAII

Neutral

2025-07-10

KALV Stock Moves More Than 30% in a Week: What Is Driving This Rally?

Zacks

Neutral

2025-07-09

Why KalVista Pharmaceuticals, Inc.’s (KALV) Stock Is Up 6.09%

AAII

Neutral

2025-07-08

Why KalVista Pharmaceuticals, Inc.’s (KALV) Stock Is Up 5.15%

AAII

Neutral

2025-07-07

Bank of America Securities Keeps Their Buy Rating on KalVista Pharmaceuticals (KALV)

TipRanks News

Neutral

2025-07-07

Why KalVista Pharmaceuticals, Inc.’s (KALV) Stock Is Up 15.86%

AAII

Neutral

News Score - Last 7 Days

Neutral

KALV

Sector Average

Media Buzz

This Week0 articles

Weekly Average0 articles

News Sentiment

This Week59%

Sector Average57%

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is KALV’s Media Buzz Sentiment?

Currently, no data Available

What is KALV’s weekly average amount of articles?

Currently, no data Available

What is KALV’s News Sentiment?

59% of articles about KALV were positive this week, compared to its sector average of 57%.

Healthcare Stocks that are Trending in the News

COOCooper Co

ANSLFAnsell

WBAWalgreens Boots Alliance

S5YASigma Healthcare Ltd

RMSYFRamsay Health Care

Showing the stocks with the most bullish news sentiment over the past week

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing